Catalyze Capital
Venture capitalAmsterdam · Pre-Seed–Series A · 8 people tracked
Find your way into Catalyze Capital
2,476 people in our graph share verified history with the Catalyze Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Catalyze Capital invests in companies that apply science and technology to create positive impact for people and the planet. Leveraging its expertise, the fund concentrates on life science, sustainable, and deep tech innovations. It provides up to €1.5 million to small and medium-sized enterprises registered in Europe, targeting companies and academic spin-offs at the Seed and Series A stages, and supports them as they grow and build value.
Source: firm website, verified Aug 16, 2026.
Team · 8 people
from the firm's website
What they invest in
from 4 of 4 portfolio companiesBiotech ×3Medical Devices ×3Digital Health ×2AI & Machine Learning ×1Climate Tech ×1Consumer ×1FemTech ×1FoodTech ×1
HQs:Sweden×2Germany×1
Investments · 4 tracked
founders shown can be your intro pathAdrenoMed AG is a clinical-stage biopharmaceutical company developing Enibarcimab (formerly Adrecizumab), a first-in-class antibody targeting the peptide Adrenomedullin to restore vascular integrity in critically ill patients, with septic shock as its lead indication.
BiotechHealthtechMedical DevicesHennigsdorf, DE
Gerald Moeller(Co-founder and former CEO of AdrenoMed; Supervisory Board member)inRichard Jones(Chief Executive Officer (CEO))inDavid Germonpré(Chief Financial Officer (CFO))in
Co-investorsBrandenburg KapitalVU Venture Partners
Gesynta Pharma is a pharmaceutical company developing non-hormonal, anti-inflammatory drug candidates that inhibit the mPGES-1 enzyme, with a lead program in endometriosis.
BiotechDigital HealthFemTechMedical DevicesStockholm, SE
Patric Stenberg(Founder)Gunilla Ekström(Founder)in
Co-investorsAmboy Street VenturesForeground CapitalHadean VenturesHealthCapIndustrifondenXGEN Venture
Melt&Marble uses precision fermentation, microbial metabolic engineering, and synthetic biology to produce fats and ingredients aimed at creating more sustainable food products.
BiotechClimate TechConsumerFoodTechNew MaterialsGothenburg, SE
Anastasia Krivoruchko(Co-founder & CEO)inFlorian David(Co-founder & CSO)inJens Nielsen(Co-founder & Chairman of the Board)inThomas Cresswell(Chief Business Officer)inTue Holdal(Chief Technology Officer)in
Co-investorsBeiersdorf Innovation FundChalmers Ventures ABIndustrifondenLever VCNordic Foodtech VC
NEL develops software-driven solutions for motion analysis and diagnostics to support epilepsy patients and their physicians.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsHadean Ventures
Portfolio news
latest coverage across their companiesMelt&Marble · finsmes.com · Dec 8, 2025
Gesynta Pharma · femtechinsider.com · Jul 23, 2025
Frequently asked questions
- What stage does Catalyze Capital invest at?
- Catalyze Capital invests at the Pre-Seed, Seed, Series A stages.
- What is Catalyze Capital's typical check size?
- Catalyze Capital typically writes checks of $1.6M.
- What sectors does Catalyze Capital focus on?
- Catalyze Capital focuses on Biotech, Cleantech, Climate Tech, Deep Tech, Impact & Social Good.
- Where is Catalyze Capital located?
- Catalyze Capital is headquartered in Amsterdam, NL.
- Who does Catalyze Capital co-invest with?
- Catalyze Capital most often shares deals with Hadean Ventures, Industrifonden, Amboy Street Ventures, among 12 tracked co-investors.
Similar investors
Boundary Capital invests in high-growth private technology companies with the aim of positively impacting millions of lives, focusing on life sciences, AI, and engineering.
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Octopus Ventures is a founder-focused European venture capital firm that backs mission-driven startups across seven core sectors, investing from idea stage through growth with a focus on pre-seed to Series A.
Giant Ventures is a venture capital firm investing in technology that transforms civilization's foundational systems across sectors including AI, energy, materials, industry, work, finance, biology and healthcare.